Friday, October 31, 2025 10/31/2025

R01 Administrative Supplement for AI Prediction of Trauma Resuscitation Responsiveness

Award Number: R01HL149670
ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 12/01/2019
PERIOD OF PERFORMANCE END DATE: 11/30/2025

Group Awards By:

View Award Description

R01 Administrative Supplement for AI Prediction of Trauma Resuscitation Responsiveness - PARENT R01 PROJECT ABSTRACT The initial resuscitation of a trauma patient is often described as chaos and the clinician directing the care must create calm while making life and death decisions often with inadequate information. Despite some advances in understanding the biology of hemorrhage, injury still accounts for over 5 million deaths per year, represents 1 out of every 10 deaths worldwide, and remains the leading U.S. cause of death for those under 45. While > 90% of trauma patients do well, the largest contribution to preventable death remains for those suffering from hemorrhage and its related complications. Trauma has a known time zero of onset which makes it an ideal model to study the immediate pathophysiologic changes associate with hemorrhage that lead to differential outcome. To date, treatment pathways are considered rudimentary reflecting attempts to optimize outcome based upon the average treatment effect, rather than being adaptable for unique patient phenotypes. The parent R01 proposal is focused on exploring a deeper understanding of the mechanistic modeling of initial patient response to injury (Aim 1) and coupling this with improved real-time point of care bedside decision support technology (Aim 2) to identify early those at risk of poor outcome. The net product of the parent proposal is to define novel patient phenotypes that may require precision resuscitation approaches to maximize outcome following hemorrhage. The goal of the parent R01 is to develop digital biomarkers for precision trauma resuscitation with a focus on understanding the cross talk between the inflammatory and coagulation profiles that occur as a systemic response to traumatic injury. The overall goal of the parent R01 project remains unchanged and are to address limitations of our current knowledge by improving forecasts of patient outcome trajectory at the point of care for those suffering from traumatic injury. The parent R01 project addresses these gaps through two interrelated aims which also remain unchanged: AIM 1. To develop a knowledge network (neural net) approach for characterizing early patient trajectory following hemorrhage. We hypothesize that (1A) predictive trajectories for mortality and complications can be ascertained through deep learning approaches; (1B) the addition of biologic data (inflammatory and coagulation markers) will further improve the prediction of patient states or unique phenotypic patient profiles (also known as digital biomarkers) attributable to differential outcome, and (1C) these phenotypes could be utilized to improve earlier recognition of patients off their predicted trajectory and thus, optimize triage and treatment pathways. AIM 2. To develop pilot prediction models for the detection of occult hemorrhage through the integration of high fidelity, integrated point-of-care data and bedside imaging. We hypothesize that the poor sensitivity for prediction of occult hemorrhage can be improved by developing (2A) an automated computer algorithm using advanced machine learning to detect any free fluid in the abdominal cavity on point- of-care sonographic images (2B) by integrating multimodality data sources with 2A, we can predict clinically significant occult hemorrhage, and (2C) combining the imaging prediction models with the knowledge network in Aim 1, we can develop pilot enhanced digital biomarkers to identify patients suffering from clinically occult hemorrhage, those most likely to develop complications, and those most likely to succumb to their injuries. Our work to date on the Parent R01 has shown that there is differential risk of thrombotic, bleeding, respiratory, and mortality outcomes based on initial coagulation profiles3-4. Our findings have suggested that biology plays a major factor in distinguishing between two seemingly identical patients who have disparate outcomes following critically injury3-19. This includes demonstrating that severely injured patients initia


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $0 )
2025	2023	UNIVERSITY OF CALIFORNIA, DAVIS	1850 RESEARCH PARK DR STE 300	DAVIS	CA	95618	YOLO	USA	Blood Diseases and Resources Research	000	5	1/13/2025	SUPPLEMENT FOR EXPANSION	$0
														Subtotal = $0

Issue Date FY: 2024 ( Subtotal = $756,268 )
2024	2024	UNIVERSITY OF CALIFORNIA, DAVIS	1850 RESEARCH PARK DR STE 300	DAVIS	CA	95618	YOLO	USA	Blood Diseases and Resources Research	002	6	6/14/2024	NON-COMPETING CONTINUATION	$61,736
2024	2024	UNIVERSITY OF CALIFORNIA, DAVIS	1850 RESEARCH PARK DR, STE 300	DAVIS	CA	95618	YOLO	USA	Blood Diseases and Resources Research	000	6	12/5/2023	NON-COMPETING CONTINUATION	$694,532
2024	2023	UNIVERSITY OF CALIFORNIA, DAVIS	1850 RESEARCH PARK DR, STE 300	DAVIS	CA	95618	YOLO	USA	Blood Diseases and Resources Research	001	5	12/15/2023	SUPPLEMENT FOR EXPANSION	$0
														Subtotal = $756,268

Issue Date FY: 2023 ( Subtotal = $1,540,645 )
2023	2023	UNIVERSITY OF CALIFORNIA, DAVIS	1850 RESEARCH PARK DR, STE 300	DAVIS	CA	95618	YOLO	USA	Blood Diseases and Resources Research	001	5	3/15/2023	NON-COMPETING CONTINUATION	$77,170
2023	2023	UNIVERSITY OF CALIFORNIA, DAVIS	1850 RESEARCH PARK DR, STE 300	DAVIS	CA	95618	YOLO	USA	Blood Diseases and Resources Research	000	5	1/18/2023	NON-COMPETING CONTINUATION	$694,532
2023	2023	UNIVERSITY OF CALIFORNIA, DAVIS	1850 RESEARCH PARK DR, STE 300	DAVIS	CA	95618	YOLO	USA	Blood Diseases and Resources Research	002	5	9/15/2023	SUPPLEMENT FOR EXPANSION	$768,943
														Subtotal = $1,540,645

Issue Date FY: 2022 ( Subtotal = $849,371 )
2022	2022	UNIVERSITY OF CALIFORNIA, DAVIS	1850 RESEARCH PARK DR, STE 300	DAVIS	CA	95618	YOLO	USA	Blood Diseases and Resources Research	002	4	6/13/2022	NON-COMPETING CONTINUATION	$77,213
2022	2022	UNIVERSITY OF CALIFORNIA, DAVIS	1850 RESEARCH PARK DR, STE 300	DAVIS	CA	95618	YOLO	USA	Blood Diseases and Resources Research	001	4	1/14/2022	NON-COMPETING CONTINUATION	$694,906
2022	2021	UNIVERSITY OF CALIFORNIA, DAVIS	1850 RESEARCH PARK DR, STE 300	DAVIS	CA	95618	YOLO	USA	Blood Diseases and Resources Research	000	3	1/13/2022	NON-COMPETING CONTINUATION	$77,252
														Subtotal = $849,371

Issue Date FY: 2021 ( Subtotal = $695,258 )
2021	2021	UNIVERSITY OF CALIFORNIA, DAVIS	1850 RESEARCH PARK DR, STE 300	DAVIS	CA	95618	YOLO	USA	Blood Diseases and Resources Research	002	3	7/15/2021	NON-COMPETING CONTINUATION	$17,591
2021	2021	UNIVERSITY OF CALIFORNIA, DAVIS	1850 RESEARCH PARK DR, STE 300	DAVIS	CA	95618	YOLO	USA	Blood Diseases and Resources Research	000	3	11/25/2020	NON-COMPETING CONTINUATION	$695,258
2021	2020	REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE	1855 FOLSOM ST STE 425	SAN FRANCISCO	CA	94143	SAN FRANCISCO	USA	Blood Diseases and Resources Research	001	1	7/15/2021	NEW	-$17,591
														Subtotal = $695,258

Issue Date FY: 2020 ( Subtotal = $790,053 )
2020	2020	UNIVERSITY OF CALIFORNIA, DAVIS	1850 RESEARCH PARK DR, STE 300	DAVIS	CA	95618	YOLO	USA	Blood Diseases and Resources Research	002	2	6/30/2020	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$772,462
2020	2020	REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE	1855 FOLSOM ST STE 425	SAN FRANCISCO	CA	94143	SAN FRANCISCO	USA	Blood Diseases and Resources Research	001	1	6/30/2020	NEW	-$772,462
2020	2020	REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE	1855 FOLSOM ST STE 425	SAN FRANCISCO	CA	94143	SAN FRANCISCO	USA	Blood Diseases and Resources Research	000	1	11/27/2019	NEW	$790,053
														Subtotal = $790,053

Grand Total All Awards = $4,631,595

Top

All Categories

About

Search

Reports

Data Submission

Award Information

R01 Administrative Supplement for AI Prediction of Trauma Resuscitation Responsiveness

Award Number: R01HL149670

ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 12/01/2019

PERIOD OF PERFORMANCE END DATE: 11/30/2025

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer